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TRAIL enhances paracetamol-induced liver sinusoidal
endothelial cell death in a Bim- and Bid-dependent
manner
A Badmann1, S Langsch1, A Keogh2, T Brunner3, T Kaufmann4 and N Corazza*,1
Paracetamol (acetaminophen, APAP) is a universally used analgesic and antipyretic agent. Considered safe at therapeutic
doses, overdoses cause acute liver damage characterized by centrilobular hepatic necrosis. One of the major clinical problems
of paracetamol-induced liver disease is the development of hemorrhagic alterations. Although hepatocytes represent the main
target of the cytotoxic effect of paracetamol overdose, perturbations within the endothelium involving morphological changes of
liver sinusoidal endothelial cells (LSECs) have also been described in paracetamol-induced liver disease. Recently, we have
shown that paracetamol-induced liver damage is synergistically enhanced by the TRAIL signaling pathway. As LSECs are
constantly exposed to activated immune cells expressing death ligands, including TRAIL, we investigated the effect of TRAIL on
paracetamol-induced LSEC death. We here demonstrate for the first time that TRAIL strongly enhances paracetamol-mediated
LSEC death with typical features of apoptosis. Inhibition of caspases using specific inhibitors resulted in a strong reduction of
cell death. TRAIL appears to enhance paracetamol-induced LSEC death via the activation of the pro-apoptotic BH3-only proteins
Bid and Bim, which initiate the mitochondrial apoptotic pathway. Taken together this study shows that the liver endothelial layer,
mainly LSECs, represent a direct target of the cytotoxic effect of paracetamol and that activation of TRAIL receptor
synergistically enhances paracetamol-induced LSEC death via the mitochondrial apoptotic pathway. TRAIL-mediated
acceleration of paracetamol-induced cell death may thus contribute to the pathogenesis of paracetamol-induced liver damage.
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Paracetamol (acetaminophen, APAP) is a widely used
analgesic and antipyretic drug.1 Although safe at therapeutic
doses, overdose causes massive liver damage characterized
by hemorrhagic centrilobular necrosis.2 Although substantial
efforts have been made to delineate the mechanisms of
paracetamol-induced liver destruction, the biochemical
events and their cellular targets leading to the disease are
still not completely understood.
Hepatocytes represent the most prominent target of
paracetamol-induced toxicity. Paracetamol is metabolized
within hepatocytes via the cytochrome P450 enzyme system
into the toxic compound N-acetyl-p-benzoquinone imine
(NAPQI), which at therapeutic doses is detoxified by
glutathione. However, overdoses lead to hepatic glutathione
depletion and NAPQI to cause mitochondrial dysfunctions
resulting in cell death.3,4
Whereas paracetamol overdose seems to lead to hepato-
cellular death displaying necrotic features3,5 mitochondrial
events linked to apoptosis have also been implicated.6,7
These include the proteolytic processing of the pro-apoptotic
Bcl-2 family member Bid into truncated tBid, the translocation
of tBid and Bax tomitochondria and the release of cytochrome
c from mitochondria into the cytosol.6,7 We have recently
shown that paracetamol-induced hepatocyte death is syner-
gistically enhanced by TNF-related apoptosis-inducing ligand
(TRAIL). Furthermore, we demonstrated that the activation of
the pro-apoptotic BH3-only protein Bim via the stress kinase
c-Jun N-terminal kinase (JNK) regulates paracetamol-
induced hepatocellular death.8
Whereas one of the major and common clinical problems of
paracetamol-induced liver disease is the development of
hemorrhagic alterations suggesting damage of the endothelial
layer, few efforts have been put into the understanding of the
fate of liver sinusoidal endothelial cells (LSECs) after
paracetamol overdoses. It has been demonstrated that
centrilobular microvascular congestion, thought to be caused
by the collapse of the sinusoidal wall and the extra vasation of
blood into the space of Disse, represents an important
1Division of Immunopathology, Institute of Pathology, University of Bern, Bern, Switzerland; 2Visceral and Transplantation Surgery, University Hospital, University
of Bern, Bern, Switzerland; 3Biochemical Pharmacology, Department of Biology, University of Konstanz, Konstanz, Germany and 4Institute of Pharmacology, University
of Bern, Bern, Switzerland
*Corresponding author: N Corazza, Institute of Pathology, University of Bern, Murtenstrasse 31, Bern, CH-3010, Switzerland. Tel: +41 31 632 32 08; Fax:
+4131 381 87 64; E-mail: nadia.corazza@pathology.unibe.ch
Received 12.9.12; revised 6.11.12; accepted 9.11.12; Edited by G Melino
Keywords: liver sinusoidal endothelial cells (LSEC); paracetamol; TRAIL; Bcl-2 homologs; apoptosis
Abbreviations: acLDL, acetylated low-density lipoprotein; APAP, acetaminophen, paracetamol; CHOP, C/EBP homologous protein; ERK, extracellular-signal
regulated kinase; ER, endoplasmatic reticulum; FITC, fluorescein isothiocyanate; FLIP, FLICE-like inhibitory protein; H&E, hematoxylin-eosin; IFN-g, interferon gamma;
LSECs, liver sinusoidal endothelial cells; JNK, c-Jun N-terminal kinase; NKT, natural-killer T-cells; NK, natural killer cell; ROS, reactive oxygen species; TRAIL, TNF-
related apoptosis-inducing ligand; PFA, paraformaldehyde; PI, propidium iodide; PBS, phosphate-buffered saline; VEGF-a, vascular endothelial growth factor-a
Citation: Cell Death and Disease (2012) 3, e447; doi:10.1038/cddis.2012.185
& 2012 Macmillan Publishers Limited All rights reserved 2041-4889/12
www.nature.com/cddis
s
o
u
r
c
e
:
 
ht
tp
s:
//
do
i.
or
g/
10
.7
89
2/
bo
ri
s.
12
98
1 
| 
do
wn
lo
ad
ed
: 
8.
5.
20
16
attribute of paracetamol-induced liver disease.9–12 These
observations suggest that during the onset of paracetamol-
induced liver damage the blood vessels are injured, and the
cells forming the barrier between the blood stream and
hepatocytes represent an additional and potentially important
target of paracetamol-induced liver damage.13 Damage of the
hepatic vasculature has been recognized as an early hallmark
of paracetamol-induced liver damage. As early as 2 h after
paracetamol challenge perturbations within the endothelium,
involving swelling of LSECs, gap formation and the coales-
cence of fenestrae have been observed, indicating that
LSECs are able to metabolize paracetamol and are suscep-
tible to its toxic metabolite.9 These changes in morphology of
the endothelium facilitate the subsequent infiltration of blood
cells and their accumulation in the space of Disse, and most
probably represent an early event in the pathogenesis of
paracetamol-induced liver injury.
As LSECs are constantly exposed to activated immune
cells expressing death ligands and we previously demon-
strated that TRAIL synergizes with paracetamol in liver
toxicity,8 we here investigated the effects of TRAIL and
paracetamol on LSEC death. We demonstrate for the first
time that TRAIL synergizes with paracetamol to induce cell
death in different endothelial cell lines as well as in primary
murine and human LSECs. We further demonstrate that the
BH3-only proteins Bim and Bid have an essential role in the
synergistic LSEC death induced by paracetamol and TRAIL.
Taken together, these data indicate that (1) LSECs represent
a direct target of the cytotoxic effect of paracetamol and
TRAIL, and (2) similar cytotoxic molecular mechanisms exist
in LSECs as in hepatocytes. Both points represent an
important and additional new piece of information to the
further understanding of liver pathology in response to
paracetamol overdoses.
Results
Paracetamol-induced endothelial cell death is
synergistically enhanced by TRAIL. We have previously
shown that TRAIL synergistically enhances paracetamol-
induced hepatocyte death.8 One of the major clinical
problems of paracetamol-induced liver disease is the
development of hemorrhagic alterations as a consequence
of endothelial layer damage.10,12 We therefore investigated
the effect of paracetamol in combination with TRAIL on
endothelial cell death. The human endothelial cell line
skHep-1 and the immortalized human umbilical vein endothe-
lial cell line EA.hy92614 were stimulated with sublethal doses
of TRAIL, increasing concentrations of paracetamol or the
combination thereof, and cell death was monitored by MTT
assay (Figure 1a) and phosphatidylserine externalization
(Figure 1b). Both endothelial cell lines were sensitive to the
cytotoxic effect of paracetamol alone, indicating that
endothelial cells express enzymes required for drug meta-
bolism. The ability of LSECs to metabolize different drugs
was already demonstrated in previous publications.13,15–17
For instance, DelLeve et al.13 showed that sinusoidal
endothelial cells are targets for acetaminophen toxicity. This
result was also corroborated by the detection of cytochrome
Figure 1 TRAIL synergizes with paracetamol in inducing endothelial cell death. The human cell lines skHep-1 or EA.hy926 were stimulated with TRAIL and paracetamol
and cell death was assessed by MTT assay (a) or by Annexin V-FITC staining 16 h after stimulation (b). Cells were treated with media or increasing concentrations of
paracetamol or with 10mM paracetamol, 30 ng/ml respectively 3 ng/ml TRAIL or the combination thereof and harvested and cytospin was performed at 600 rpm for 2 min.
Cells were microscopically visualized after hematoxylin and eosin staining (c). Mean values±S.D. triplicates are shown for MTT assay, which were repeated four times,
yielding similar results. A typical experiment out of three is shown for Annexin V staining. *** Po0.001, **Po0.01 versus paracetamol alone treated cells
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P450 mRNA expression (CYP2E1) in both cell lines
(Supplementary Figure 1). Interestingly, the combination of
TRAIL with increasing concentrations of paracetamol leads
to a significant increase of endothelial cell death (Figures 1a
and b). This synergistic induction of cell death was confirmed
by increased numbers of cells with typical apoptotic
morphology, that is, condensed cytoplasm and nuclei, within
6 h after treatment with TRAIL and paracetamol (Figure 1c).
Caspase activation is crucially involved in paracetamol
plus TRAIL-mediated endothelial cell death. Whereas
paracetamol overdose seems to lead to a necrotic type of cell
death in hepatocytes, apoptotic events have also been
observed. We therefore investigated the contribution of
effector caspases in TRAIL- and paracetamol-induced
endothelial cell death. Neither paracetamol nor TRAIL alone
led to the activation of caspases, as detected by western blot
(Figure 2a) or by DEVDase assay (Figure 2b). However,
combined treatment of cells with paracetamol and TRAIL
leads to the activation of the effector caspase 3, as
demonstrated by proteolytic caspase 3 processing and by
the DEVDase assay. The contribution of caspases in
paracetamol plus TRAIL-induced endothelial cell death was
further supported by the analysis of endothelial cell death
using cell-permeable Hoechst 33342 and propidium iodide
(PI) (Figure 2c) and MTT assay (Figure 2d). Using both
assays, endothelial cell death induced by paracetamol and
TRAIL was efficiently attenuated by the pan-caspase
inhibitor Z-VAD-fmk.
Critical role for Bim and Bid in the synergistic induction
of endothelial cell death by TRAIL and paracetamol. We
previously demonstrated that Bim represents an important
player in paracetamol-induced hepatocyte death.8 Similarly,
it had been demonstrated in hepatocytes that paracetamol
induces the proteolytic activation of Bid.7 We therefore
analyzed whether the pro-apoptotic Bcl-2 homologs Bim
and Bid represent important initiators of mitochondrial
alterations upon paracetamol plus TRAIL treatment. Western
blot analysis revealed that treatment of skHep-1 and
EA.hy926 cells with paracetamol resulted in a strong
induction of Bim expression (Figure 3a). In contrast, no
increase in Bim levels was observed in both cell lines after
treatment with TRAIL alone. Combined treatment of cells
with TRAIL and paracetamol did not further increase the
expression of Bim. Instead, no Bid processing was detect-
able upon stimulation with paracetamol or TRAIL alone. Only
the combined treatment with paracetamol and TRAIL lead to
the processing of Bid into its active tBid form (p15) in both
cell lines.
To define whether the increase in Bim protein levels is a
consequence of protein stabilization or of a transcriptional
induction of the bim gene, we analyzed bim-mRNA levels.
Sub-lethal doses of TRAIL did not affect bim-mRNA expres-
sion in both cell lines. In contrast, paracetamol strongly
promoted bim-mRNA expression. No synergy between
paracetamol and TRAIL in promoting bim-mRNA expression
was detected (Figure 3b).
To define the relative contribution of Bid and Bim in
paracetamol plus TRAIL induced endothelial cell death, the
expression of these pro-apoptotic Bcl-2 homologs was
downregulated by RNA interference, as depicted in
Supplementary Figure 2. Cell death in response to para-
cetamol with or without TRAIL was quantified by measuring
AnnexinV binding (Figure 3c). In skHep-1 cells downregula-
tion of Bim or Bid alone resulted only in minimal reduction of
endothelial cell death after administration of paracetamol plus
TRAIL. However, combined knockdown of Bid and Bim
efficiently reduced cell death as demonstrated by the
reduction in AnnexinV positivity. Interestingly, in EA.hy926
cell death was already significantly reduced upon knockdown
of either Bim or Bid, most probably due to a more efficient
knockdown of Bid and Bim compared to skHep-1
(Supplementary Figure 2). The activation and role of Bim
and Bid in paracetamol plus TRAIL-induced death suggests
an activation of the mitochondrial apoptotic pathway. We
therefore analyzed the release of cytochrome c from the
mitochondrial inter-membrane space (M) into the cytosol by
western blot. Upon stimulation with paracetamol plus TRAIL,
release of cytochrome c was detected in both cell lines as
illustrated in Figure 3d.
Paracetamol-induced Bim expression is JNK dependent.
JNK activity has been shown to be involved in paracetamol-
induced liver cell death.18,19 Moreover, we previously
demonstrated that JNK is implicated in the transcrip-
tional control of Bim expression after paracetamol treatment
of hepatocytes.8 We therefore investigated whether
JNK activation participates in paracetamol plus TRAIL-
mediated endothelial cell death. Inhibition of JNK activity
with JNK inhibitor V decreased the paracetamol-induced
bim-mRNA expression in a dose-dependent manner in both
cell lines (Figure 4a). To define whether inhibition of bim
expression influences the sensitivity of endothelial cells to
paracetamol plus TRAIL treatment, we treated cells for
30min with JNK inhibitor V prior to adding paracetamol with
or without TRAIL. As shown in Figure 4b, JNK inhibition
resulted in a significant reduction of caspase activation as
detected by DEVDase activity. The reduction of DEVDase
activity correlated with the reduced Bim protein levels after
JNK inhibitor V treatment as revealed by western blot
(Figure 4c).
Paracetamol plus TRAIL sensitizes primary murine and
human LSEC death in a Bim- and caspase-dependent
manner. Our in vitro results with both human endothelial cell
lines strongly indicate that TRAIL synergizes with paraceta-
mol in killing endothelial cells. To confirm that these findings
in cell lines are relevant for primary LSECs, we investigated
the effect of paracetamol plus TRAIL on ex vivo cultured
primary murine and human LSECs. Analogous to skHep-1
and EA.hy926, neither paracetamol nor TRAIL alone induced
significant cell death in murine or human LSECs as
visualized by Hoechst 33342 and PI staining (Figure 5a). In
contrast, both murine and human LSECs displayed syner-
gistic cell death induction upon treatment with paracetamol
plus TRAIL. Similarly to skHep-1 and EA.hy926, this
synergistic effect was caspase-dependent as demonstrated
by reduced PI positivity in the presence of the broad caspase
inhibitor Z–VAD–fmk (Figure 5a) and DEVDase activity in
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Figure 2 Caspases are crucially involved in paracetamol plus TRAIL mediated endothelial cell death. skHep-1 or EA.hy926 cells were treated with paracetamol (10 or
20mM), TRAIL (30 ng/ml; respectively 3 ng/ml) or both for 6 h, and the protein level of cleaved caspase 3 was analyzed by western blot (a). Tubulin was used to normalize
protein loadings. Cell death was assessed by DEVD cleavage assay 7 h after stimulation (b). Cell death was assed by microscopy after Hoechst 33342 and PI staining (c), or
by MTT assay (d). skHep-1 or EA.hy926 cells were pretreated (30min) with 10mM caspase inhibitor (ZVAD, ZV) and stimulated with increasing concentrations of paracetamol,
30, respectively 3 ng/ml TRAIL, or both for 16 h. Mean values±S.D. triplicates are shown for MTT and DEVDase assays. A typical experiment out of five is shown for cleaved
caspases 3. Representative pictures are shown for microscopic analysis. ***Po0.001, **Po0.01 versus paracetamol or paracetamol and TRAIL stimulation
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murine LSECs after treatment with paracetamol plus TRAIL
Figure 5d.
In human as well as murine LSECs, paracetamol induced
expression of Bim both at the mRNA and at the protein level
(Figures 5c, b and e). To further confirm the importance of Bim
and Bid in paracetamol plus TRAIL-mediated cell death, we
isolated LSECs from Bim / and Bid / mice. Figure 6
shows that Bim / as well as Bid / LSECs display
attenuated induction of cell death after paracetamol plus
TRAIL stimulation compared to wild-type LSECs. Taken
together, these findings indicated that LSECs represent a
direct target of the synergistic cytotoxic effect of paracetamol
plus TRAIL, and that the mitochondrial effector molecules Bim
and Bid have an essential role. These results were also
confirmed in vivo. Sixty minutes after administration of an
overdose of paracetamol, wild-type and Bim / mice were
injected with ovalbumin-Texas Red to specifically stain
endothelial cells and were sacrificed 30min later. Compared
to liver sections of PBS-treated wild-type animals, LSEC
staining was absent in the affected regions of livers from
paracetamol-treated wild-type mice (Figure 7). In contrast,
paracetamol treatment of Bim / mice only minimally
affected the endothelial structure as compared to wild-type
mice, supporting the results obtained from ex vivo cultured
LSECs and indicating that Bim also has a central role in
paracetamol-induced LSEC death in vivo.
Discussion
Although hepatocytes are the main target of the toxic effect of
paracetamol, several reports indicate that the hepatic
vasculature is also injured during paracetamol-induced liver
damage.9,10,13 Hemorrhagic alteration as a consequence of
endothelial layer damage is thus likely a major problem of
Figure 3 Bim and Bid are crucially involved in the synergistic induction of endothelial cell death by paracetamol plus TRAIL. skHep-1 or EA.hy926 cells were treated for 6 h
with 10 or 20mM paracetamol, and 30 ng/ml, respectively, 3 ng/ml TRAIL, or the combination thereof, and Bid, Bim and tubulin as loading control were detected by western
blot (a). bim-mRNA expression was measured by quantitative RT-PCR in both cell lines. GAPDH was used to normalize bim-expression levels (b). skHep-1 or EA.hy926 cells
were transfected with control (siNone), Bim- or Bid-specific siRNA or the combination of both. Apoptosis sensitivity to paracetamol (10mM), TRAIL (30, respectively 3 ng/ml) or
both was analyzed by Annexin V staining after 16 h (c). Cytoplasmic (C) and mitochondrial fractions (M) were isolated. Cytochrome c (Cyto c), porin and, for comparison, twere
analyzed in the different fractions by western blot (d). Mean values±S.D. triplicates are shown for quantitative RT-PCR. A typical experiment out of five is shown for western
blot analysis. bim-mRNA expression, siRNA downregulation as well as cytochrome c western blot were repeated three times yielding similar results. *Po0.05, **Po0.005,
***Po0.001
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paracetamol-induced liver disease. Perturbations of the
endothelium involves swelling of LSECs, gap formation and
the coalescence of fenestrae, facilitating the subsequent
leakage of red blood cells through these gaps.9,10,12,13,20 Our
experiments indicate that paracetamol not only induces
morphological changes in LSECs but also directly triggers
cytotoxic effector mechanisms.
LSECsexhibited onlyminor sensitivity to the cytotoxic effect of
paracetamol alone, whereas addition of TRAIL leads to a
synergistic increase in cell death. We have previously demon-
strated that TRAIL-deficient mice were less susceptible to
paracetamol-induced liver damage, and that this partial protec-
tion clearly correlatedwith reducedhemorrhagic alterations.8 It is
still amajor unsolved question whether paracetamol induces cell
death of LSEC directly or whether the observed LSEC damage
and the resulting hemorrhagic alterations are primarily a
consequence of the release of cytotoxic compounds from dying
hepatocytes. Our in vitro experiments support the idea that
LSECs represent a direct target of TRAIL and paracetamol;
however, the possibility that toxic compounds released by
hepatocytesmay further contribute to the injury of the endothelial
layer cannot be excluded.
These in vitro experiments reflect the observations made
in vivo. In areas where paracetamol overdose was detrimental
to hepatocytes, LSECs were equally absent (Figure 7). These
observations suggest that both cell types, that is, hepatocytes
as well as LSECs, are destroyed by an overdose of
paracetamol.
Our results also confirmed amajor cell death-regulating role
of TRAIL in paracetamol-induced liver damage. The relevant
source of endogenous TRAIL, though, is still uncertain. Liver-
homing leukocytes including Kupffer cells, natural killer (NK)
and natural killer T (NKT) cells have been shown to express
TRAIL and to participate in the development of several forms
of liver injury.21–23 Thus, we propose that liver-homing
leukocytes within the sinusoids represent the source of TRAIL
involved in the amplification of the cytotoxic effect of
paracetamol on LSECs. This is in accordance to the report
ofMasson et al.24 who demonstrated a pathogenic role of NKT
and NK cells in paracetamol-induced liver injury in mouse
experiments, in which DMSO was used to dissolve para-
cetamol. They showed that DMSO was able to activate
hepatic NKT and NK cells as indicated by increased NKT cell
numbers and higher intracellular levels of cytotoxic effector
molecules, such as IFNg and granzyme B.24 Moreover, it is
well accepted that IFNg modulates the expression of TRAIL
and TRAIL-Rs,25 suggesting that TRAIL expressed on
activated NKT and NK cells could participate in paraceta-
mol-induced liver damage.
Even though the hepatotoxic activity of paracetamol
has been widely investigated, a conclusive picture
on the mechanisms involved in paracetamol-induced liver
Figure 4 Paracetamol induced Bim expression is JNK-dependent. skHep-1 or EA.hy926 cells were pretreated (60min) with increasing concentrations of the JNK inhibitor
V (1, 3 and 10mM) and stimulated with 10mM paracetamol for 6 h. bim-mRNA expression was measured by quantitative RT-PCR. GAPDH was used to normalize bim-
expression levels (a). skHep-1 and EA.hy926 cells were treated as described above and Bim protein expression was analyzed by western blot. Tubulin was used to normalize
protein loadings (b). After pretreatment with 3 mM JNK inhibitor V, cells were stimulated with 10mM paracetamol and 30 ng/ml, respectively 3 ng/ml TRAIL, or the combination
thereof for 6 h and DEVD cleavage was measured (c). Mean values±S.D. triplicates are shown for quantitative RT-PCR and DEVDase assay. A typical experiment out of
three is shown for western blot analysis. **Po0.01 versus paracetamol treatment, ***Po0.001 versus paracetamol treatment
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damage is still missing. One of the reasons is that the outcome
of paracetamol-induced liver disease is most probably an
interplay of several signaling events. Whereas paracetamol
overdose seems to lead to a necrotic cell death in hepatocyte,
we and others have demonstrated that mitochondrial events
generally linked to apoptosis are also implicated.6,8 Our
previous study identified JNK and Bim as critical players in
paracetamol-induced hepatocyte.
With this current study we add new findings to the under-
standing of the mechanisms involved in paracetamol-induced
Figure 5 Paracetamol plus TRAIL induce cell death in primary murine as well as human LSECs in a Bim- and caspase-dependent manner. Murine and human LSECs
were pretreated (30min) with Z–VAD–fmk and stimulated with 10mM paracetamol, 30 ng/ml TRAIL or the combination thereof for 16 h, and visualized microscopically after
Hoechst 33342 and PI staining. Inserts show a two-fold magnification from the center of the picture (a). Cells were treated with 10mM paracetamol and 30 ng/ml TRAIL, or the
combination of both for 6 h; and Bim, cleaved caspase 3 and Tubulin as loading control, were detected by western blot (b, e). Cells were stimulated for 6 h with 10mM
paracetamol and bim-mRNA expression was measured by quantitative RT-PCR. GAPDH was used to normalize bim-expression levels (c). Murine and human LSECs were
stimulated as described and DEVD cleavage was measured after 6 h (d, f). Mean values±S.D. triplicates are shown for DEVDase assay. A typical experiment out of four is
shown for microscopy analysis. Western blot for Bim was repeated two times, yielding similar results.Mean values±S.D. triplicates of independent pooled LSEC isolation are
shown for RT-PCR
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Figure 6 Bim- and Bid-deficient primary LSECs are protected from paracetamol plus TRAIL-induced cell death. Murine LSECs were isolated from wild-type (WT), Bim-
(Bim / ) and Bid-deficient (Bid / ) mice, were treated with 10mM paracetamol and 30 ng/ml TRAIL or the combination thereof for 16 h and cell death was visualized
microscopically after Hoechst 33342 and PI staining. Inserts show a two-fold magnification from the center of the picture
Figure 7 Bim /mice display more ovalbumin-Texas Red positive LSECs in paracetamol damaged liver sections. Wild type (WT) and Bim-deficient (Bim / ) mice
were injected with PBS as control or 400mg/kg body weight paracetamol for 90min. Thirty minutes before the end of the experiment they were injected i.v. with 50mg
ovalbumin-Texas Red. After perfusion fixation and paraffin embedding, liver sections were counterstained with DAPI, mounted in poly-Dabco and analyzed by fluorescence
microscopy. A typical liver section out of six mice per group is shown
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liver damage. We demonstrate that similar mechanisms are
operative in paracetamol-induced cell death in LSECs and
hepatocytes. Paracetamol treatment of LSECs triggered the
induction and activation of Bim, and downregulation of Bim
resulted in a significant protection of LSECs from paracetamol
plus TRAIL-induced cytotoxicity. In line with this proposed role
of Bim in the control of LSEC death, the importance of Bim in
endothelial cell death in the vasculature of solid tumors has
recently been demonstrated.26
Similarly to hepatocytes, we identified JNK as a regulator
of Bim transcription in LSECs. JNK has previously been
associated with paracetamol-induced cell death.18,19
Henderson et al.18 demonstrated that paracetamol-induced
hepatic JNK activation, and that JNK inhibition in vivo
markedly reduced mortality of mice treated with paracetamol,
with a significant reduction in hepatic necrosis and apoptosis.
Similarly we demonstrated that activation of JNK downstream
of paracetamol induces transcriptional expression of bim.8
The present study corroborates the existence of similar
mechanisms in LSECs. Moreover, we demonstrate that Bid
represents an important mediator in LSEC death. Although
TRAIL does not seem to be required for the activation of Bim,
TRAIL synergizes with paracetamol in activating Bid most
likely via induction of caspase 8 activation and subsequent
processing of Bid. It is still unclear why Bid cleavage is only
detectable upon simultaneous treatment of cells with TRAIL
and paracetamol but not upon treatment with a sub-lethal
dose of TRAIL alone. An explanation could be that intracel-
lular events activated by the administration of paracetamol
leads to an increased susceptibility to TRAIL-induced activa-
tion of the mitochondrial apoptosis pathway. Sung et al.27
demonstrated that activation of the CHOP pathway sensitizes
colon cancer cells to TRAIL-induced apoptosis. Moreover, it
was also demonstrated that paracetamol induced endoplas-
mic reticulum (ER) stress. Nagy et al.28 showed that
intraluminal redox imbalance of the ER and subsequent
activation of pro-apoptotic events are involved in hepatocel-
lular damage caused by paracetamol overdose. Beside this,
Martı´n-Pe´rez et al.29 recently demonstrated that ER stress
sensitizes cells to TRAIL-induced cell death through down-
regulation of c-FLIP and upregulation of TRAIL-R2. To test
whether downregulation of c-FLIP or upregulation of TRAIL-
R2 could be involved in the increased sensitivity of LSECs to
TRAIL-induced apoptosis upon paracetamol treatment, we
analyzed the expression of c-FLIP and TRAIL-R1 and R2.
Although TRAIL-R1 and R2 were minimally affected by the
treatment at the mRNA level (data not shown), we did
observed a reduction of c-FLIP expression (Supplementary
Figure 3). However, this could possibly also reflect the
caspase-mediated cleavage and consumption of cFLIP after
combined treatment of cells with TRAIL plus paracetamol. In
line with this notion we demonstrated that a pan-caspase
inhibitor was effective in attenuating murine as well as human
LSEC death.
In summary, we demonstrated that LSECs represent a
direct target of TRAIL and paracetamol-induced
cytotoxicity, and that the resulting damage of the endothelial
layer may represent an early event during paracetamol-
induced liver damage contributing to the progression of the
disease.
Materials and Methods
Cell lines. Human endothelial cell line skHep-1 (ATCC: HTB-52) (kindly
provided by C Hammer, Division of Pathology, University of Bern, Switzerland)
were cultured in DMEM containing 10% FCS, 1% HEPES (Sigma-Aldrich GmbH,
Buchs, Switzerland), 1% L-alanyl-L-glutamine (Biochrom AG, Berlin, Germany),
0.1% gentamycin (Sigma-Aldrich GmbH, Buchs, Switzerland) and 10mM
hydrochloric acid (Merck KGaA, Darmstadt, Germany). Human umbilical vain
endothelial cell line EA.hy926 (ATCC: CRL-2922) (kindly provided by Professor A
Huwiler, Institute of Pharmacology, University of Bern, Bern, Switzerland) were
cultured in RPMI-1640 containing 10% FCS, 1% L-alanyl-L-glutamine and 0.1%
gentamycin.
Mice and in vivo experiments. Bim / and Bid / mice (on the
C57BL/6 background) were kindly provided by A Strasser (Walter and Eliza Hall
Institute, Melbourne, Australia). Wild-type C57BL/6 mice were purchased from
Harlan (Fu¨llingdorf, Switzerland). All mice were bred and kept in individually
ventilated cages in the Central Animal Facility of the Department of Medicine,
University of Bern. Animal experiments were approved by the animal
experimentation committee of the State of Bern. After O/N fasting, mice were
injected i.p. with 400ml PBS or APAP (400mg/kg body weight) dissolved in warm
PBS. After 60min, the mice were injected i.v. with 50 mg ovalbumin-Texas Red
(Molecular Probes, Lucerne, Switzerland) dissolved in 200ml PBS, and sacrificed
30min later. The livers were perfused with 3% paraformaldehyde through the
portal vein. After fixation for 24 h the livers were embedded in paraffin. Sections of
5 mm were cut for subsequent staining with DAPI and analyses by fluorescence
microscopy.
Cell death assay (MTT). skHep-1 and EA.hy926 cell lines were grown in
logarithmic phase, harvested and plated in 96-well flat bottom plates. After 24 h,
cells were treated with increasing concentrations of paracetamol (N-acetyl-4-
aminophenol, Sigma-Aldrich GmbH, Buchs, Switzerland) and recombinant human
TRAIL (R&D Systems, Schonenbuch/Basel, Switzerland) for 16 h. Cell viability
was then assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay (Sigma-Aldrich GmbH, Buchs, Switzerland) and normalized to
untreated cell controls.
AnnexinV/PI staining. After treatment, cell death was monitored by
AnnexinV-FITC (eBioscience, San Diego, CA, USA) and PI staining. Briefly, cells
were harvested, centrifuged and resuspended in 50 ml AnnexinV binding buffer
(10mM Hepes, pH 7.4, 150mM NaCl, 5 mM MgCl2 and 1.5 mM CaCl2) containing
3 mg/ml AnnexinV-FITC. The cells were stained for 10min, washed with AnnexinV
binding buffer, resuspended in 200ml AnnexinV binding buffer containing 1 mg/ml
PI and analyzed on a FACScan flow cytometer (Becton Dickinson, Heidelberg,
Germany). The percentage of AnnexinV-FITC positive cells was calculated using
the Flow Jo software 8.8.6 (FlowJo, Ashland, OR, USA).
Caspase 3/7 activity assay (DEVDase assay). skHep-1 and EA.hy926
were grown in logarithmic phase, harvested and plated in 96-well flat bottom
plates. After O/N adherence, cells were stimulated with 5, 10 or 20mM APAP and/
or 30 or 3 ng/ml TRAIL, and harvested after 6 h. In some experiments cells were
pretreated with the JNK inhibitor V (Calbiochem, Merck KGaA, Darmstadt,
Germany). Cells were washed and lysed in 100ml PBS containing 1% Triton
X-100 (Sigma-Aldrich GmbH, Buchs, Switzerland). After overnight lysis at
 20 1C, cells were centrifuged for 10min at 1500 g at 4 1C, supernatant was
harvested and 50ml were mixed with 50ml HEPES Buffer (100mM HEPES, pH
7.5, 20% glycerol, 0.5 mM EDTA, 4mMDTT) containing 100mM Ac-DEVD-AFC
(Enzo Life Sciences AG, Lausen, Switzerland). Reactions were performed for
90min at 37 1C, and enzymatic activity was measured on a spectrofluorometer
(400 nm excitation, 505 nm emission). Background fluorescence was measured by
incubating caspase substrate with lysis buffer.
Western blot analysis. skHep-1 and Ea.hy926 cell lines were treated as
indicated, prior to lysis in cell lysis buffer containing 50mM Tris pH 6.8, 2% SDS
(Fluka Chemie GmbH, Buchs, Switzerland), 100mMDTT (Merck KGaA,
Darmstadt, Germany), 10% glycerol and 0.1% bromphenolblue (Sigma-Aldrich
GmbH, Buchs, Switzerland). Cell lysates were separated by standard 15% SDS-
PAGE and transferred to nitrocellulose membranes (Whatman GmbH, Dassel,
Germany). Bim (1:1000, Sigma-Aldrich GmbH, Buchs, Switzerland), tBid
(1:1000,30), cleaved caspase 3 (1:1000, Cell Signaling Technology, Bioconcepts,
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Allschwil, Switzerland), cytochrome c (1:1000, BD Biosciences, Allschwil,
Switzerland), porin (1:2000, Calbiochem, Merck, Zug, Switzerland) and FLIP
(1:1000, Enzo life science, Lausen, Switzerland) were detected by incubation of
membranes with the respective primary antibodies and corresponding horseradish
peroxidase-labeled secondary antibodies. Signals were visualized by using the
SuperSignal West Pico chemiluminescence reagents (Thermo Fisher Scientific
Inc., Rockford, IL, USA) and detected on a Fujifilm LAS 4000 imaging system
(Fujifilm Corporation, Akasaka, Japan). Equal protein loading was confirmed by
detection of tubulin (1:5000, Sigma-Aldrich GmbH, Buchs, Switzerland).
Subcellular fractionation. One million skHep-1 and Ea.hy926 cells l were
plated and stimulated as indicated. Cell were then harvested, centrifuged and their
pellets were permeabilized for 5min on ice with 200mg/ml digitonin (Sigma-Aldrich
GmbH, Buchs, Switzerland) dissolved in 200ml digitonin buffer (250mM sucrose
70mM KCl, 137mM NaCl, 4.3mM Na2HPO4, 1.4 mM KH2PO4, pH 7.2 ) and
protease inhibitor cocktail tablets (Roche Diagnostics GmbH, Mannheim,
Germany). Cells were centrifuged for 5min at 1000 g at 4 1C and cytosolic
protein fraction was collected from the supernatant. The pellets were then
solubilised in mitochondrial lysis buffer (50mM Tris, pH 7.4, 2mM EDTA, 0.3%
Nonidet P-40, 150mM NaCl, 2 mM EGTA, 0.2% Triton X-100) followed by
centrifugation for 10min at 10 000 g at 4 1C. The mitochondrial protein fraction
was collected from the supernatant. Cytosolic and mitochondrial fractions were
analyzed for cytochrome c and porin by western blotting.
Quantitative RT-PCR. Human and mouse bim-mRNA expression was
detected by quantitative RT-PCR. Briefly, cells were lysed in TRI reagent (Sigma-
Aldrich) and RNA was isolated. A total of 2 mg of RNA were reverse transcribed
using a high capacity kit (Applied Biosystems, Rotkreuz Zug, Switzerland).
Quantitative RT-PCR was performed on the RT-PCR 7500 machine (Applied
Biosystem, Rotkreuz Zug, Switzerland) using SYBR green and Quantitec primer
assays (QIAGEN, Hilden, Germany). GAPDH was used to normalize bim-
expression levels.
Downregulation of Bim and Bid by RNA interference. Cells were
transfected with 10 nM control, Bim- or Bid-specific siRNA (Dharmacon, Lafayette,
CO, USA) and 12ml Hyperfect reagents (Qiagen AG, Hombrechtikon, Switzerland)
in 6-cm-culture dishes for 24 h. Cells were harvested and replated into 24-well or
96-well plates. After additional O/N culture, cells were stimulated as indicated for
1 h or 16 h, respectively. Cells were either harvested for cell death assessment by
AnnexinV-FITC/PI staining or for DEVDase assay analysis. Bim and Bid
downregulation was controlled by western blot (Supplementary Figure 2).
Isolation of primary murine LSECs. Murine LSECs were isolated as
described previously.31 In brief, mice were euthanized, the vena cava was cut and
the liver lobes were perfused with 0.05% collagenase for 20 sec. Liver
parenchymal cells were dissociated by shaking for maximum 20min at
240 r.p.m. and subsequently passed through a 250mm filter. A Nycodens density
gradient centrifugation (Axonlab, Baden, Switzerland) was applied to further
separate LSECs. The cell suspension was labeled with anti-CD146 MicroBeads
(Miltenyi Biothec GMBH, Bergisch Gladbach, Germany) and magnetic separation
was performed on MACS columns. Isolated LSECs were cultured on collagen-
coated plates in DMEM (Sigma-Aldrich GmbH, Buchs, Switzerland) with 10%
FCS, 2% L-alanyl-L-glutamine and 0.1% gentamycin for 2 days. LSEC purity,
generally more than 95%, was confirmed by the incorporation of fluorescence-
labeled acetylated low-density lipoprotein (data not shown), which results in a
typical endosomal fluorescence pattern when observed under the fluorescence
microscope. Cells were then rested for at least 1 day before they were used in
experiments.
Isolation of primary human LSECs. Human liver endothelial cells were
isolated from liver tissue from patients undergoing surgical liver resection. The
tissue was collected with informed consent and under local ethics committee
approval of the University of Bern. Approximately 30 g of liver was cut into 2mm3
pieces and digested in 50ml PBS containing 10mg/ml collagenase 1A (Sigma-
Aldrich GmbH) for 90min at 37 1C. The resultant solution was then filtered through
a sterile 0.5 mm steel mesh, the supernatant centrifuged at 300 g for 8 min, and
the pellet then resuspended on 10ml PBS. This digest was then layered on a
33%/77% Percoll density gradient, centrifuged for 30min at 800 g 4 1C and the
non-parenchymal layer removed, pelleted and resuspended in 500ml of PBS.
Endothelial cells were isolated from this fraction by immunomagnetic selection
using a mouse anti-CD31 antibody (Dako, Baar, Switzerland), followed by an anti-
mouse IgG Dynabead, 30min incubation with each and magnetic separation was
performed on MACS columns. Isolated LSECs were cultured on collagen-coated
plates. Human LSECs were cultured in SFM endothelial basal media (Gibco,
Luzern, Switzerland) with 10% human serum, 0.1% gentamycin, 5 ng/ml
hepatocyte growth factor (HGF, Peprotech, Luzern, Switzerland) and 10 ng/ml
vascular endothelial growth factor (VEGF, Peprotech).
Fluorescence microscopy. Paraffin sections from paracetamol- and
control-treated mice injected with ovalbumin-Texas red were deparaffinized and
stained for 2min with 600 nM DAPI (Invitrogen, Lucerne, Switzerland), washed in
TBS and embedded in poly-Dabco, prior to analysis by fluorescence microscopy
(Olympus IX81 FluoView FV1000, Volketswil, Switzerland).
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